Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 May;17(5):313-314.
doi: 10.1038/s41569-020-0369-9.

Reply to: 'Interaction between RAAS inhibitors and ACE2 in the context of COVID-19'

Ying-Ying Zheng  1   2 , Yi-Tong Ma  3 , Jin-Ying Zhang  4   5 , Xiang Xie  6
Affiliations
Comment

Reply to: 'Interaction between RAAS inhibitors and ACE2 in the context of COVID-19'

Ying-Ying Zheng et al. Nat Rev Cardiol. 2020 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Comment in

Comment on

References

    1. Mourad J-J, Levy BI. Interaction between RAAS inhibitors and ACE2 in the context of COVID-19. Nat. Rev. Cardiol. 2020 doi: 10.1038/s41569-020-0368-x. - DOI - PMC - PubMed
    1. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat. Rev. Cardiol. 2020 doi: 10.1038/s41569-020-0360-5. - DOI - PMC - PubMed
    1. Ferrario CM, et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005;111:2605–2610. doi: 10.1161/CIRCULATIONAHA.104.510461. - DOI - PubMed
    1. Li Y, et al. Angiotensin-converting enzyme inhibition attenuates lipopolysaccharide-induced lung injury by regulating the balance between angiotensin-converting enzyme and angiotensin-converting enzyme 2 and inhibiting mitogen-activated protein kinase activation. Shock. 2015;43:395–404. doi: 10.1097/SHK.0000000000000302. - DOI - PubMed
    1. Wösten-van Asperen RM, et al. Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1–7) or an angiotensin II receptor antagonist. J. Pathol. 2011;225:618–627. doi: 10.1002/path.2987. - DOI - PubMed

Substances